Dr Kathleen Grant, a senior lecturer at Cape Peninsula of Technology (CPUT) Department of Biomedical Sciences, is part of a group of breast cancer specialists who are looking at innovative ways to save thousands of women from having to undergo chemotherapy.
She speaks to CapeTalk's Kieno Kammies about a new study which holds great promise for women diagnosed with early-stage breast cancer.
Grant says they are at a stage where they are exploring the clinical utility of the test to see if it is applicable within the South African population.
It is an extensive test which is genetically based. You don't want to unnecessarily go and check people and make them pay for genetic testing when the normal hepatology could actually give them those results.— Dr Kathleen Grant, Senior lecturer - Cape Peninsula of Technology
We can avoid at least 60% of women going through chemotherapy in early stage breast cancer. Unfortunately, if it's at an advanced stage we have to go in all guns blazing.— Dr Kathleen Grant, Senior lecturer - Cape Peninsula of Technology
Grant says two co-authors of the study based in Cape Town are currently using this method of genetic testing to help patients with early-stage breast cancer.
To hear the rest of the conversation, listen below:
This article first appeared on CapeTalk : New SA study holds promise for women diagnosed with early-stage breast cancer